Literature DB >> 27405456

Are General Physicians Prepared for Struggling Skin Cancer?-Cross-Sectional Study.

Ana Filipa Duarte1, Altamiro da Costa-Pereira2, Veronique Del-Marmol3,4, Osvaldo Correia5,6,7.   

Abstract

The aim of this study is to evaluate the role of general practitioners (GP) in selecting higher risk population for skin cancer screening. GP's training was organized to examine a specific high risk population consisting mainly of fisherman and farmers in a city of North of Portugal. Health care professionals of local health units training was performed by two dermatologists 2 months before the screening. During 8 weeks GPs selected patients with skin cancer suspicious lesions and/or risk factors consecutively from their regular consultation. These selected patients were referred to a dermatologist evaluation. Six dermatologists using manual dermoscopy examined the previously selected patients. One hundred eight patients have been screened, 35 % of which were males and 65 % females, with a mean age of 54 years. Full skin evaluation by dermatologists revealed 31 % of actinic keratosis, 5 % of leucoplasia, 7 % of basal cell carcinoma, 8 % of squamous cell carcinoma, and 1 % of melanoma. Cohen's kappa coefficient between dermatologist and GPs was 0.18. Selective screening with collaboration of GPs allowed the detection of more cases of skin cancer than the nonselective screenings in the literature. Although the diagnostic agreement between GPs and dermatologists was not good, our results indicate that active collaboration of dermatologists with primary health care units for selective skin cancer screening, including post graduated courses on their own health units, can be a way of optimizing early detection of cutaneous pre malignant and malignant lesions.

Entities:  

Keywords:  General physicians; Screening; Skin cancer

Mesh:

Year:  2018        PMID: 27405456     DOI: 10.1007/s13187-016-1078-2

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  11 in total

1.  Socioeconomic status and non-melanoma skin cancer: a nationwide cohort study of incidence and survival in Denmark.

Authors:  M Steding-Jessen; F Birch-Johansen; A Jensen; J Schüz; S K Kjær; S O Dalton
Journal:  Cancer Epidemiol       Date:  2010-07-17       Impact factor: 2.984

2.  The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010.

Authors:  R J T van der Leest; E de Vries; J-L Bulliard; J Paoli; K Peris; A J Stratigos; M Trakatelli; T J E M L Maselis; M Situm; A C Pallouras; J Hercogova; Z Zafirovik; M Reusch; J Olah; M Bylaite; H C Dittmar; L Scerri; O Correia; L Medenica; I Bartenjev; C Guillen; A Cozzio; O V Bogomolets; V del Marmol
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-09-23       Impact factor: 6.166

3.  Brief questions highlight the need for melanoma information campaigns.

Authors:  Janet A Foote; Catherine M Poole
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

4.  Cancer incidence predictions in the North of Portugal: keeping population-based cancer registration up to date.

Authors:  Clara Castro; Luís Antunes; Nuno Lunet; Maria José Bento
Journal:  Eur J Cancer Prev       Date:  2016-09       Impact factor: 2.497

5.  Diagnostic and referral accuracy of family doctors in melanoma screening: effect of a short formal training.

Authors:  P Carli; V De Giorgi; E Crocetti; L Caldini; C Ressel; B Giannotti
Journal:  Eur J Cancer Prev       Date:  2005-02       Impact factor: 2.497

6.  A retrospective study comparing the accuracy of prehistology diagnosis and surgical excision of malignant melanomas by general practitioners and hospital specialists.

Authors:  M Bakhai; D Hopster; R Wakeel
Journal:  Clin Exp Dermatol       Date:  2009-09-23       Impact factor: 3.470

Review 7.  Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future.

Authors:  A J Stratigos; A M Forsea; R J T van der Leest; E de Vries; E Nagore; J-L Bulliard; M Trakatelli; J Paoli; K Peris; J Hercogova; M Bylaite; T Maselis; O Correia; V Del Marmol
Journal:  Br J Dermatol       Date:  2012-08       Impact factor: 9.302

Review 8.  Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.

Authors:  Louisa G Gordon; David Rowell
Journal:  Eur J Cancer Prev       Date:  2015-03       Impact factor: 2.497

9.  Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015.

Authors:  M Arnold; C Holterhues; L M Hollestein; J W W Coebergh; T Nijsten; E Pukkala; B Holleczek; L Tryggvadóttir; H Comber; M J Bento; Ch S Diba; R Micallef; M Primic-Žakelj; M I Izarzugaza; J Perucha; R Marcos-Gragera; J Galceran; E Ardanaz; R Schaffar; A Pring; E de Vries
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-08-21       Impact factor: 6.166

10.  Diagnostic competence of Swiss general practitioners in skin cancer.

Authors:  Nina Badertscher; Ralph P Braun; Ulrike Held; Reto Kofmehl; Oliver Senn; Günther F L Hofbauer; Pascal O Rossi; Michel Wensing; Thomas Rosemann; Ryan Tandjung
Journal:  Swiss Med Wkly       Date:  2013-07-29       Impact factor: 2.193

View more
  3 in total

1.  The Effect of Educational Intervention Based on PRECEDE Model on Promoting Skin Cancer Preventive Behaviors in High School Students.

Authors:  Ali Khani Jeihooni; Milad Moradi
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

Review 2.  Skin Cancer Education Interventions for Primary Care Providers: A Scoping Review.

Authors:  Ashley E Brown; Maleka Najmi; Taylor Duke; Daniel A Grabell; Misha V Koshelev; Kelly C Nelson
Journal:  J Gen Intern Med       Date:  2022-06-16       Impact factor: 6.473

Review 3.  Educational Interventions to Support Primary Care Provider Performance of Diagnostic Skin Cancer Examinations: A Systematic Literature Review.

Authors:  Eliza L Posada; Kyle C Lauck; Tiffaney Tran; Kate J Krause; Kelly C Nelson
Journal:  J Cancer Educ       Date:  2022-01-18       Impact factor: 2.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.